Michael E. Shore

Micheal Shore joined DavosPharma in 2007. He is responsible for business development with the emerging biotech and pharmaceutical companies in the Bay Area and Pacific Northwest. Prior to DavosPharma, Mike began his career with Ciba-Geigy as a process chemist. He then joinied Agouron Pharmaceuticals/WarnerLambert/Pfizer where he was responsible for process development, scale-up, optimization, technology transfer, validation and the manufacture of Viracept®, Agouron’s small molecule protease inhibitor. Mr. Shore has also worked at Amylin Pharmaceuticals as a Project Manager. Mr. Shore holds a B.S. degree in Organic Chemistry from Florida State University. He has also had direct involvement with the filing of six INDs and two NDAs.